S. 2837 · 115th Congress
Preventing Drug Diversion Act of 2018
- Stage
- Reported from committee
- Sponsor
- Maggie Hassan
- Introduced
- 2018-05-14
- Latest action
- 2018-06-19 · Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Summary
Preventing Drug Diversion Act of 2018
This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion.
Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners.
Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.